(1 - 4 von 8
)
Adrian Rawcliffe to Succeed James Noble as AdaptimmuneGlobeNewswire
www.globenewswire.com
— Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer · James Noble will transition to become a Non-Executive Director.
Adrian Rawcliffe to Succeed Ja - GuruFocus.com
www.gurufocus.com
Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer, Stocks: ADAP,WVE,GWPH, release date:Jun 27,
Change at the top at Adaptimmune as Noble stands downPharmaphorum
pharmaphorum.com
— ... James Noble, is standing down, to be replaced by chief financial officer and former GlaxoSmithKline executive Adrian Rawcliffe.
sortiert nach Relevanz / Datum